Anti-obesity effect of Neoagaro-oligosaccharides with overweight and obese subjects: a 16-week, randomized, double-blind, placebo-controlled clinical trial

This trial aimed to evaluate the anti-obesity effects and safety of Neoagaro-oligosaccharides (NAOs) in humans in a 16 week, randomized, double-blind, placebo-controlled clinical trial.

Source: BMC Complementary and Alternative Medicine - October 19, 2023 Category: Complementary Medicine Authors: Hyang-Im Baek, Ki-Chan Ha, Yu Kyung Park, Je Hyeon Lee, Eun Joo Kim, Hye-Jeong Ko and Jong Cheon Joo Tags: Research Source Type: research